1. 2020
  2. Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 Apr 2020, In : Cancers. 12, 4, 1017.

    Research output: Contribution to journalArticle

  3. Preclinical Targeted alpha- and beta(-)-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Windhorst, A. D., van der Aa, F., Lecocq, Q., Breckpot, K., Morgenstern, A., Bruchertseifer, F., Lahoutte, T., Devoogdt, N. & D'Huyvetter, M., Apr 2020, In : Cancers. 12, 4, 1017.

    Research output: Contribution to journalArticle

  4. 2019
  5. Development of LAG-3 nanobodies as potent cancer imaging tracers

    Lecocq, Q., Awad, R. M., Zeven, K., De Vlaeminck, Y., de Mey, W., Debie, P., Puttemans, J., Goyvaerts, C., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., Dec 2019, In : Annals of Oncology. 30

    Research output: Contribution to journalMeeting abstract (Journal)

  6. Influence of the degree of chelator conjugation on the physicochemical properties of Nanobody PET tracers

    Debie, P., Baudhuin, H., Puttemans, J., Hernot, S., Xavier, C. & Lahoutte, T., Oct 2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, SUPPL 1, p. S435-S435

    Research output: Contribution to journalMeeting abstract (Journal)

  7. Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases

    Puttemans, J., Lahoutte, T., D'Huyvetter, M. & Devoogdt, N., 1 Aug 2019, In : Pharmaceutics. 11, 8, 23 p., 376.

    Research output: Contribution to journalScientific review

  8. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior

    Dekempeneer, Y., Back, T., Aneheim, E., Jensen, H., Puttemans, J., Xavier, C., Keyaerts, M., Palm, S., Albertsson, P., Lahoutte, T., Caveliers, V., Lindegren, S. & D'Huyvetter, M., Aug 2019, In : Molecular Pharmaceutics. 16, 8, p. 3524-3533

    Research output: Contribution to journalArticle

  9. CAM-H2 effectively targets and treats HER2 positive brain lesions: A comparative preclinical study with trastuzumab

    Puttemans, J., D'Huyvetter, M., Windhorst, B., Lahoutte, T. & Devoogdt, N., May 2019, In : Annals of Oncology. 30

    Research output: Contribution to journalMeeting abstract (Journal)

Previous 1 2 Next

ID: 11130341